HEADER HYDROLASE/HYDROLASE INHIBITOR 21-FEB-11 3QSD TITLE STRUCTURE OF CATHEPSIN B1 FROM SCHISTOSOMA MANSONI IN COMPLEX WITH TITLE 2 CA074 INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: CATHEPSIN B-LIKE PEPTIDASE (C01 FAMILY); COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 87-340; COMPND 5 SYNONYM: CATHEPSIN B1 ISOTYPE 1; COMPND 6 EC: 3.4.22.1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SCHISTOSOMA MANSONI; SOURCE 3 ORGANISM_COMMON: BLOOD FLUKE; SOURCE 4 ORGANISM_TAXID: 6183; SOURCE 5 GENE: CB1.1, SMP_103610; SOURCE 6 EXPRESSION_SYSTEM: PICHIA PASTORIS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 4922; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: X33; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PPICZALPHAA KEYWDS CYSTEINE PEPTIDASE, DIGESTIVE TRACT, HYDROLASE-HYDROLASE INHIBITOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR P.REZACOVA,A.JILKOVA,J.BRYNDA,M.HORN,M.MARES REVDAT 3 13-SEP-23 3QSD 1 REMARK SEQADV LINK REVDAT 2 26-OCT-11 3QSD 1 JRNL REVDAT 1 10-AUG-11 3QSD 0 JRNL AUTH A.JILKOVA,P.REZACOVA,M.LEPSIK,M.HORN,J.VACHOVA,J.FANFRLIK, JRNL AUTH 2 J.BRYNDA,J.H.MCKERROW,C.R.CAFFREY,M.MARES JRNL TITL STRUCTURAL BASIS FOR INHIBITION OF CATHEPSIN B DRUG TARGET JRNL TITL 2 FROM THE HUMAN BLOOD FLUKE, SCHISTOSOMA MANSONI. JRNL REF J.BIOL.CHEM. V. 286 35770 2011 JRNL REFN ISSN 0021-9258 JRNL PMID 21832058 JRNL DOI 10.1074/JBC.M111.271304 REMARK 2 REMARK 2 RESOLUTION. 1.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.3.0037 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 22.33 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 93.6 REMARK 3 NUMBER OF REFLECTIONS : 52880 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.116 REMARK 3 R VALUE (WORKING SET) : 0.114 REMARK 3 FREE R VALUE : 0.155 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2805 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.34 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2554 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 62.07 REMARK 3 BIN R VALUE (WORKING SET) : 0.1310 REMARK 3 BIN FREE R VALUE SET COUNT : 144 REMARK 3 BIN FREE R VALUE : 0.2290 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1991 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 42 REMARK 3 SOLVENT ATOMS : 472 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 8.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 12.33 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.28000 REMARK 3 B22 (A**2) : 0.11000 REMARK 3 B33 (A**2) : 0.17000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.047 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.025 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.273 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.979 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.967 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2258 ; 0.018 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3078 ; 1.808 ; 1.965 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 301 ; 5.967 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 102 ;32.161 ;24.216 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 413 ;12.012 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 13 ;13.296 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 307 ; 0.120 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1755 ; 0.013 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1177 ; 0.241 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1547 ; 0.318 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 387 ; 0.182 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 69 ; 0.275 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 91 ; 0.293 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1385 ; 2.019 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2181 ; 2.679 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1025 ; 3.404 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 874 ; 4.501 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): 2410 ; 2.033 ; 3.000 REMARK 3 SPHERICITY; FREE ATOMS (A**2): 472 ;10.028 ; 3.000 REMARK 3 SPHERICITY; BONDED ATOMS (A**2): 2177 ; 5.028 ; 3.000 REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3QSD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-JAN-11. REMARK 100 THE DEPOSITION ID IS D_1000064042. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-OCT-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.1 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9791 REMARK 200 MONOCHROMATOR : SI111 DOUBLE-CRYSTAL REMARK 200 MONOCHROMATOR REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : HKL-3000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 55759 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.300 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.5 REMARK 200 DATA REDUNDANCY : 5.500 REMARK 200 R MERGE (I) : 0.05300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 26.2900 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.32 REMARK 200 COMPLETENESS FOR SHELL (%) : 61.6 REMARK 200 DATA REDUNDANCY IN SHELL : 3.10 REMARK 200 R MERGE FOR SHELL (I) : 0.28100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 1HUC REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.06 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.09 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M AMMONIUM ACETATE, 0.1M NA REMARK 280 CITRATE, 30% (V/W) PEG 1500, 10MM NA ACETATE PH 5.5, CPR REMARK 280 CONCENTRATION = 5 MG/ML PROTEIN:RESERVOIR - 1:1 , VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 293K, PH 6.1 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 16.58850 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 45.30500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 39.58000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 45.30500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 16.58850 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 39.58000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 VAL A 70 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLU A 142 O HOH A 664 1.80 REMARK 500 OE2 GLU A 142 O HOH A 457 2.09 REMARK 500 O HOH A 392 O HOH A 478 2.09 REMARK 500 O HOH A 599 O HOH A 609 2.11 REMARK 500 O HOH A 386 O HOH A 419 2.14 REMARK 500 OG SER A 136 O HOH A 437 2.15 REMARK 500 O HOH A 368 O HOH A 418 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 NH2 ARG A 84 O HOH A 395 1455 1.87 REMARK 500 O HOH A 375 O HOH A 604 1455 1.87 REMARK 500 ND2 ASN A 122 O HOH A 604 1455 1.89 REMARK 500 O HOH A 464 O HOH A 470 4555 1.98 REMARK 500 O HOH A 560 O HOH A 682 1655 1.98 REMARK 500 O HOH A 673 O HOH A 721 2554 2.12 REMARK 500 O HOH A 440 O HOH A 664 1455 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 SER A 162 CA SER A 162 CB 0.100 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 95 -154.39 61.80 REMARK 500 HIS A 167 55.58 34.67 REMARK 500 LYS A 208 45.22 -103.60 REMARK 500 LYS A 208 35.09 -96.58 REMARK 500 LYS A 282 -0.03 75.77 REMARK 500 ASN A 293 171.06 71.25 REMARK 500 GLU A 316 49.18 -141.14 REMARK 500 ALA A 319 -159.07 -158.58 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 THE UNBOUND FORM OF THE INHIBITOR CA-074 HAS AN OXIRANE RING. ITS REMARK 600 CONFIGURATION CHANGES(OPENS UP) UPON BINDING TO SG OF CYS100. THIS REMARK 600 BOUND OPEN CONFIGURATION OF THE INHIBITOR IS REPRESENTED IN 074 REMARK 630 REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE INHIBITOR REMARK 630 MOLECULE NAME: [PROPYLAMINO-3-HYDROXY-BUTAN-1,4-DIONYL]-ISOLEUCYL- REMARK 630 PROLINE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 074 A 324 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: 3CN LMR ILE PRO REMARK 630 DETAILS: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 074 A 324 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PEG A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 325 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 2 DBREF 3QSD A 70 323 UNP Q8MNY2 Q8MNY2_SCHMA 87 340 SEQADV 3QSD ALA A 168 UNP Q8MNY2 THR 185 ENGINEERED MUTATION SEQADV 3QSD ALA A 283 UNP Q8MNY2 THR 300 ENGINEERED MUTATION SEQRES 1 A 254 VAL GLU ILE PRO SER SER PHE ASP SER ARG LYS LYS TRP SEQRES 2 A 254 PRO ARG CYS LYS SER ILE ALA THR ILE ARG ASP GLN SER SEQRES 3 A 254 ARG CYS GLY SER CYS TRP ALA PHE GLY ALA VAL GLU ALA SEQRES 4 A 254 MET SER ASP ARG SER CYS ILE GLN SER GLY GLY LYS GLN SEQRES 5 A 254 ASN VAL GLU LEU SER ALA VAL ASP LEU LEU SER CYS CYS SEQRES 6 A 254 GLU SER CYS GLY LEU GLY CYS GLU GLY GLY ILE LEU GLY SEQRES 7 A 254 PRO ALA TRP ASP TYR TRP VAL LYS GLU GLY ILE VAL THR SEQRES 8 A 254 GLY SER SER LYS GLU ASN HIS ALA GLY CYS GLU PRO TYR SEQRES 9 A 254 PRO PHE PRO LYS CYS GLU HIS HIS THR LYS GLY LYS TYR SEQRES 10 A 254 PRO PRO CYS GLY SER LYS ILE TYR LYS THR PRO ARG CYS SEQRES 11 A 254 LYS GLN THR CYS GLN LYS LYS TYR LYS THR PRO TYR THR SEQRES 12 A 254 GLN ASP LYS HIS ARG GLY LYS SER SER TYR ASN VAL LYS SEQRES 13 A 254 ASN ASP GLU LYS ALA ILE GLN LYS GLU ILE MET LYS TYR SEQRES 14 A 254 GLY PRO VAL GLU ALA GLY PHE THR VAL TYR GLU ASP PHE SEQRES 15 A 254 LEU ASN TYR LYS SER GLY ILE TYR LYS HIS ILE THR GLY SEQRES 16 A 254 GLU THR LEU GLY GLY HIS ALA ILE ARG ILE ILE GLY TRP SEQRES 17 A 254 GLY VAL GLU ASN LYS ALA PRO TYR TRP LEU ILE ALA ASN SEQRES 18 A 254 SER TRP ASN GLU ASP TRP GLY GLU ASN GLY TYR PHE ARG SEQRES 19 A 254 ILE VAL ARG GLY ARG ASP GLU CYS SER ILE GLU SER GLU SEQRES 20 A 254 VAL THR ALA GLY ARG ILE ASN HET 074 A 324 27 HET PEG A 1 7 HET ACT A 325 4 HET ACT A 2 4 HETNAM 074 [PROPYLAMINO-3-HYDROXY-BUTAN-1,4-DIONYL]-ISOLEUCYL- HETNAM 2 074 PROLINE HETNAM PEG DI(HYDROXYETHYL)ETHER HETNAM ACT ACETATE ION HETSYN 074 CA-074; [N-(L-3-TRANS-PROPYLCARBAMOYL-OXIRANE-2- HETSYN 2 074 CARBONYL)-L-ISOLEUCYL-L-PROLINE] FORMUL 2 074 C18 H31 N3 O6 FORMUL 3 PEG C4 H10 O3 FORMUL 4 ACT 2(C2 H3 O2 1-) FORMUL 6 HOH *472(H2 O) HELIX 1 1 SER A 78 TRP A 82 1 5 HELIX 2 2 CYS A 85 THR A 90 5 6 HELIX 3 3 SER A 99 SER A 117 1 19 HELIX 4 4 SER A 126 CYS A 134 1 9 HELIX 5 5 LEU A 139 GLY A 143 5 5 HELIX 6 6 ILE A 145 GLU A 156 1 12 HELIX 7 7 PRO A 210 LYS A 215 5 6 HELIX 8 8 ASP A 227 GLY A 239 1 13 HELIX 9 9 ASP A 250 TYR A 254 5 5 HELIX 10 10 ASP A 309 ILE A 313 5 5 SHEET 1 A 5 PHE A 76 ASP A 77 0 SHEET 2 A 5 THR A 266 GLU A 280 -1 O TRP A 277 N PHE A 76 SHEET 3 A 5 VAL A 241 TYR A 248 -1 N VAL A 247 O LEU A 267 SHEET 4 A 5 VAL A 317 ARG A 321 -1 O THR A 318 N GLU A 242 SHEET 5 A 5 SER A 220 ASN A 223 -1 N TYR A 222 O ALA A 319 SHEET 1 B 5 PHE A 76 ASP A 77 0 SHEET 2 B 5 THR A 266 GLU A 280 -1 O TRP A 277 N PHE A 76 SHEET 3 B 5 ALA A 283 ALA A 289 -1 O ALA A 289 N ARG A 273 SHEET 4 B 5 TYR A 301 VAL A 305 -1 O PHE A 302 N ILE A 288 SHEET 5 B 5 ILE A 258 TYR A 259 1 N TYR A 259 O ARG A 303 SSBOND 1 CYS A 85 CYS A 114 1555 1555 2.13 SSBOND 2 CYS A 97 CYS A 141 1555 1555 2.06 SSBOND 3 CYS A 133 CYS A 199 1555 1555 2.04 SSBOND 4 CYS A 134 CYS A 137 1555 1555 2.10 SSBOND 5 CYS A 170 CYS A 203 1555 1555 2.03 SSBOND 6 CYS A 178 CYS A 189 1555 1555 2.04 LINK SG CYS A 100 C6 074 A 324 1555 1555 1.84 SITE 1 AC1 20 LYS A 86 GLN A 94 SER A 95 GLY A 98 SITE 2 AC1 20 SER A 99 CYS A 100 TRP A 101 GLY A 143 SITE 3 AC1 20 GLY A 144 LEU A 146 HIS A 180 HIS A 181 SITE 4 AC1 20 ILE A 193 GLY A 269 HIS A 270 TRP A 292 SITE 5 AC1 20 GLU A 316 HOH A 339 HOH A 360 HOH A 383 SITE 1 AC2 11 HOH A 41 HOH A 46 ASP A 77 ARG A 79 SITE 2 AC2 11 ALA A 89 THR A 246 GLY A 268 HOH A 494 SITE 3 AC2 11 HOH A 534 HOH A 642 HOH A 692 SITE 1 AC3 7 HOH A 52 HOH A 62 ARG A 92 GLU A 124 SITE 2 AC3 7 SER A 163 HOH A 432 HOH A 570 SITE 1 AC4 7 GLN A 121 LYS A 215 HIS A 216 ARG A 217 SITE 2 AC4 7 HOH A 366 HOH A 552 HOH A 679 CRYST1 33.177 79.160 90.610 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.030141 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012633 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011036 0.00000